Management focuses on growth opportunities NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) — Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that it entered into a convertible debt financing facility of up to $3M, to be drawn down at the option of the company (See the company’s Form 8-K filed on April 23rd, 2018). New and... Read more
60-90 Minute Microbial ID of 2,700 Species from Positive Blood Cultures, Combined with Functional Testing of Cephalosporin- and Carbapenem-Resistance on MALDI Biotyper®, Addresses Clinical Need MADRID, April 20, 2018 /PRNewswire/ — New CE-IVD FastSepsityper® solution: for MALDI-Biotyper (MBT) identification (ID) of over 2,700 microbial species from Positive Blood Cultures (PBC) with less hands-on time; Novel... Read more
FRANKLIN LAKES, N.J., April 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today introduced several new informatics and automation solutions for clinical laboratories, which may play a critical role in the fight against infectious diseases and antimicrobial resistance. The new molecular, microbiology and software solutions will be showcased... Read more
New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening (ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon Plus™ Cancer NGS Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon... Read more
SEOUL, South Korea, April 17, 2018 /PRNewswire/ — Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, announced that it will attend the 28th European Congress of Clinical Microbiology and Infectious Diseases (“ECCMID 2018”) taking place in Madrid, Spain, from April 21 to 24, 2018, where it will introduce the “combination test,” which is a high-efficiency solution that diagnoses... Read more
Thermo Fisher Scientific Launches Oncomine Childhood Cancer Research Assay and Establishes International Childhood Oncology Network CHICAGO, April 16, 2018 /PRNewswire/ — AACR 2018 — One in 285 children born in the U.S. this year alone will be diagnosed with cancer before their 20th birthday1, yet, until recently, too little was known about the genetic alterations... Read more
Chalfont St Giles, UK – 17 April 2018 — GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene and cell therapies. The new, prefabricated and modular KUBio biomanufacturing facility is designed, constructed, assembled and fully fitted-out to current... Read more
Chalfont St Giles, UK – 17 April 2018 – GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics, including viral vector based vaccines, oncolytic viruses and gene and cell therapies. The new, prefabricated and modular KUBio https://www.genewsroom.com/press-releases/ges-new-factory-box-accelerates-production-viral-vector-based-therapeutics Read more
SEATTLE, April 16, 2018 /PRNewswire/ — RareCyte, Inc., a global rare cell detection and liquid biopsy company, announces its newest product, CyteFinder HT in conjunction with the American Association for Cancer Research (AACR) Annual Meeting in Chicago April 15 through 18. CyteFinder HT, RareCyte’s newest member of the CyteFinder family, enables high-speed whole slide imaging with up to six channels... Read more
NEW YORK & SAN DIEGO–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) and Illumina, Inc. (NASDAQ: ILMN) today announced a collaboration that will utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally commercialize in-vitro diagnostic (IVD) assays in support of Bristol-Myers Squibb’s oncology portfolio. The companies plan to develop a diagnostic version of the Illumina TruSight Oncology... Read more